Greg Johnson

Greg Johnson

Executive Director, Data Sciences

Subject Expert
About

Greg Johnson is a seasoned expert in clinical data sciences with over 30 years of experience across Quotient Sciences and previously with Chiltern, Kendle, Charles River, and Inveresk Research. He specializes in early-phase clinical trials and has led global biometrics operations supporting Phase I–IV studies.

At Quotient Sciences, Greg has held senior leadership roles for over a decade, currently serving as Executive Director of Data Sciences within the Scientific Consulting team. He works closely with sponsors to optimize trial design and execution, bringing deep expertise in database programming, data management, statistical analysis, and medical writing.

Expertise & focus areas
Clinical Pharmacology Services
Clinical Pharmacology

Clinical Pharmacology Info Sheet

10 March 2025 Read More

Latest news from Quotient Sciences

More News
News & Announcements, Nottingham, UK, Artificial Intelligence, Translational Pharmaceutics®, Formulation Development Quotient Sciences and Acesion Pharma Announce Collaboration on AI-Enhanced Formulation Development to Advance Atrial Fibrillation Pipeline By: Dr. Andrew Lewis
Read More
News & Announcements, Artificial Intelligence, Translational Pharmaceutics®, Formulation Development Quotient Sciences shortlisted for "Best Use of AI in Clinical Development & Trial Innovation" at the Scrip Awards 2026 By: Dr. Andrew Lewis
Read More